Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSc
Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSciences for up to $140 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.